Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134743) titled 'Multi-omics Profiling and Organoid Functional Verification of Immune Microenvironment Reprogramming in Mastitis-Mammary Carcinoma Transition' on Oct. 20.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Xiyuan Hospital, Chinese Academy of traditional Chinese Medicine
Condition:
Non-Puerperal Mastitis
Breast Benign Tumor
Breast Malignant Tumor
breast mass
Intervention:
Group A (Malignant Breast Tumor Group):None
Group B (Benign Breast Tumor Group):None
Group C (Non-lactational Mastitis Group):None
Group A (Malignant Breast Tumor):None
Group B (Benign Breast Lesion):None
Recruitmen...